Nonpharmacological approaches to the control of high blood pressure. Final report of the Subcommittee on Nonpharmacological Therapy of the 1984 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.
This report reviews a variety of nonpharmacological approaches used to control arterial blood pressure. Of all the modalities considered, only three had sufficient scientific support to warrant recommendation for inclusion in hypertension treatment programs. Each of these three modalities--weight control, alcohol restriction, and sodium restriction--was found to be capable not only of independently controlling blood pressure (particularly in patients with mild hypertension) but also of reducing the number and dosage of prescribed pharmacological agents, should their prescription be indicated. Weight reduction was found to reduce the risk from elevated arterial pressure as well as overall cardiovascular morbidity and mortality. However, because the rate of recidivism was exceedingly high in these studies, close and continuous patient follow-up is considered necessary. Excessive alcohol intake is associated in many studies with proportionally higher arterial pressures and an increased prevalence of hypertension. Therefore, the recommendation of moderation in alcohol consumption to less than 2 oz of ethanol daily for patients with hypertension is supported. Restriction of dietary sodium to less than 2 g/day was the only other nonpharmacological approach with sufficient support to be recommended as a treatment for hypertension. Although long-term studies are sorely lacking, sodium restriction has been shown to be manageable and safe and probably will benefit those hypertensive patients who are sodium-sensitive.
D000428:Alcohol Drinking; D000818:Animals; D001676:Biofeedback, Psychology; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D002110:Caffeine / Q000009:adverse effects; D002136:Calcium, Dietary; D004039:Diet, Sodium-Restricted; D014676:Diet, Vegetarian; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D004041:Dietary Fats / Q000008:administration & dosage; D004043:Dietary Fiber / Q000008:administration & dosage; D004044:Dietary Proteins / Q000008:administration & dosage; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000628:therapy*; D008274:Magnesium / Q000502:physiology; D008297:Male; D009538:Nicotine / Q000009:adverse effects; D009765:Obesity / Q000150:complications / Q000628:therapy; D005082:Physical Exertion; D011188:Potassium / Q000627:therapeutic use; D012064:Relaxation Therapy; D012964:Sodium / Q000009:adverse effects; D014029:Tobacco Use Disorder / Q000150:complications; D014131:Trace Elements / Q000502:physiology
D002136:Calcium, Dietary; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004043:Dietary Fiber; D004044:Dietary Proteins; D014131:Trace Elements; D002110:Caffeine; D009538:Nicotine; D012964:Sodium; D008274:Magnesium; D011188:Potassium